• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Shall we treat all patients with hepatitis C, and if not, why? Certainly, injecting drug users must not be an exclusion criterion

HL Tillmann, AJV Thompson

Digestion | KARGER | Published : 2008

DOI: 10.1159/000173732

University of Melbourne Researchers

Prof Alexander Thompson's Profile Picture
Prof Alexander Thompson Author

Dr Alexander Thompson's Profile Picture
Dr Alexander Thompson Author

Citation metrics

1Scopus
1Web of Science
1Dimensions

Keywords

Infectious Diseases
32 Biomedical and Clinical Sciences
3214 Pharmacology and Pharmaceutical Sciences
Chronic Liver Disease and Cirrhosis
Infection
Emerging Infectious Diseases
Science & Technology
Quality-Of-Life
Digestive Diseases
Plus Ribavirin
Hepatitis
Life Sciences & Biomedicine
Substance Misuse
3 Good Health and Well Being
Interferon-Alpha-2b
Hepatitis - C
Liver Disease
Gastroenterology & Hepatology

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224